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ABSTRACTSResults: There was a total of 91 excised BCC and 48 excised SCC. In the BCC
subgroup, incomplete excision rate was 19% with no recurrences. Addition-
ally, the rateof incompleteexcisions in theSCCsubgroupwas20%witha4.17%
rate of recurrence. These were either dealt conservatively or re-excised
Discussion: Our re-audit revealed that the department had kept closely to
the BAD guidelines. As a result, there were low levels of morbidity and no
mortalities.0225 IMPROVING THE RECOGNITION OF ACUTE KIDNEY INJURY
IN THE ACUTE SURGICAL SETTING USING AN ELECTRONIC WARNING
SYSTEM
Andrew Rajkumar, Karl Payne, Amin El-Tahir. Royal Derby General Hospital,
Derby, UK
Aim: The aim of this study was to determine if accurate recognition and referral
of acute kidney injury (AKI) in acute surgical patients is being undertaken
Method: Casenotes of patients presenting with AKI to the Surgical
Admissions Unit during a one month period were audited. As an inter-
vention an electronic warning system of AKI (grade I-III) was added to the
biochemistry result software used within our hospital. Re-audit was then
undertaken.
Results: Our data shows a prevalence of AKI within acute surgical patients
of 3.5% (13/369) and 4.5% (22/487) respectively. The formal documentation
in casenotes of AKI improved from 23% (3/13) to 59% (13/22). In total, 42.9%
(15/32) of patients presented with AKI on a background of chronic renal
impairment. In both audits all patients with AKI grade II-III were reviewed
by a renal physician within 24hrs.
Conclusion: AKI in surgical patients is a potentially reversible condition,
associated with an increase in operative mortality and morbidity. It is the
responsibility of the surgical trainee clerking the patient to recognise, treat,
and refer AKI accordingly. This study highlights the beneﬁt of an electronic
warning system tobringAKI to the attention of the clerking surgical trainee.0226 CRICOPHARYNGEAL DILATATION FOR THE LONG-TERM
TREATMENT OF DYSPHAGIA IN OCULOPHARYNGEAL MUSCULAR
DYSTROPHY
Joseph Manjaly 1, Peter Vaughan-Shaw 2, Oliver Dale 3, Susan Tyler 1,
Jonathan Corlett 1, Roger Frost 1. 1 Salisbury NHS Foundation Trust,
Salisbury, UK; 2 Southampton University Hospitals NHS Trust,
Southampton, UK; 1 Royal Berkshire NHS Foundation Trust, Reading, UK
Introduction: Oculopharyngeal muscular dystrophy (OPMD) is a rare
autosomal dominant, progressive degenerative muscle disorder featuring
dysphagia with limited long-term treatment options. This is the ﬁrst study
to describe use of repeated endoscopic dilatation for OPMD. Safety and
efﬁcacy are evaluated over a 15-year period.
Methods: All patients at our unit with genetically-conﬁrmed OPMD were
included (n¼9). Cricopharyngeal dilatation was performed with a wire
guided 18mm Savary-Gilliard bougie. Repeat dilatation was offered when
symptoms recurred. Symptom severity prior to initial dilatation and at
follow-up was evaluated using the Sydney Swallow Questionnaire (SSQ).
Results: Median treatment period was 13 years (range 3-15), median
number of dilatations per patient was 7.2 (1-16) and median interval
between treatments was 15 months (4.5-45). All patients recorded sus-
tained symptom improvement. Mean SSQ score was 1108/1700 (SD
272.9) prior to ﬁrst dilatation and 298/1700 (SD189.1) at last follow-up,
representing a 73% decrease (95% CI 52-94) in degree of dysphagia
symptoms (Paired t-test, p ¼ 0.0001). All mean scores for individual
questions showed signiﬁcant improvement (p<0.05). No adverse events
were reported with all patients maintaining oral feeding at last follow-up.
Conclusions: Repeated cricopharyngeal dilatation is a safe, effective, well-
tolerated and long-lasting treatment for dysphagia in OPMD.0230 SUPERFICIALISATION OF ARTERIOVENOUS FISTULAE FOR RENAL
DIALYSIS ACCESS IN OBESE PATIENTS
Teum Wilmink, Henry Ferguson, Sarah Powers, Clive Allen. Birmingham
Hearlands Hoapital, Birmingham, UKIntroduction: Radiocephalic or brachiocephalic arteriovenous ﬁstulae
(AVF) are the preferred form of access for dialysis. In obese patients AVF
may not be utilised because veins are too deep for needling. No literature
exists as to the longevity of superﬁcialised ﬁstulae compared to contem-
poraneous ﬁstulae in non-obese patients.
Methods: Retrospective analysis of superﬁcialisations and type-AVF
matched controls from a prospectively maintained database. Creation
date, dialysis-start date, failure date, or date of death, age sex, type AVF and
diabetes were recorded.
Results: 11 superﬁcialisation procedures and 50 gender and type-AVF
matched controls were from November 2003 till May 2009. There were no
signiﬁcant differences in age and presence of diabetes in both groups,
although there were slightly less women and more diabetics in the
controls. As would be expected, time to ﬁrst needling was signiﬁcantly
longer in the superﬁcialisation group (P¼0.005), but eventual ﬁstula
survival was comparable (log rank test, c2¼0.24, P¼0.62).
Conclusion: While superﬁcialisation requires a longer time to ﬁrst
needling when compared to a simple ﬁstula, when the procedure is
successfully completed, it produces a useable ﬁstula, which has compa-
rable survival to a standard ﬁstula in a non-obese patient. This has not
previously been reported in the literature.0231 ADMINISTRATION OF BONE MARROW STROMAL CELLS
FACILITATE AXONAL REGENERATION IN THE HEMISECTED ADULT RAT
SPINAL CORD
Kush Bhatt 1,2, Mitsuhiro Enomoto 1,2, Takeshi Hirai 1,2, Kenichi
Shinomiya 1,2. 1 Imperial College London, London, UK; 1 Tokyo Medical and
Dental University, Tokyo, Japan
Background: Spinal Cord Injury has a lack of effective surgical treatment.
Bone Marrow Stromal Cells (BMSC) and artiﬁcial extracellular matrices
have been shown to aid. We proposed the combined use of BMSCs with
a Honeycomb Collagen (HC) matrix to aid axonal regeneration.
Method: In-vitro study of rat Dorsal Root Ganglia onto BMSC infused HC
scaffolds compared against HC controls were evaluated after 10 days of
growth. An in-vivo study of cord hemisection followed, with the injury site
being surgically implanted with HC or BMSC+HC scaffolds. 4 weeks post
injury the cords were evaluated for injury volume compared to total
volume. Basso Beattie Bresnahan (BBB) score and sub score was used to
analyse motor recovery.
Results: Explants showed a signiﬁcant difference in neurite length, with
BMSC+HC producing 3x growth (p value 0.0004). The hemisection model
showed motor recovery was signiﬁcantly higher in the BMSC+HC group in
both the BBB score and subscore (p ¼ 0.03 & p ¼ 0.005 respectively) with
a tendency of BMSC+HC to have a smaller injury volume.
Conclusion: We successfully showed that BMSCs have efﬁcacy compared
to controls in both in-vitro and in-vivo regeneration, with a higher func-
tional recovery. Therefore both structural and cellular support is needed
for an effective recovery.0234 EMERGENCY HERNIA REPAIRS: CAN IT BE AVOIDED?
Madhusoodhana Hebbar, Harriet Gossage, Umesh Parampalli, Mazin
Sayegh. Western Sussex Hospitals NHS Trust, Worthing, UK
Aims: We did this study to investigate whether patients undergoing
emergency hernia repair could have avoided it, and to propose strategies
for managing hernias in our Trust.
Methods: We studied all patients undergoing emergency hernia repair in
our CEPOD theatre for a year. The data collected included patient demo-
graphics, type of hernia, duration, symptomatic or not, medical attention
received and outcome.
Results: There were 57 emergency hernia repairs for analysis during the
study period. 21 (37%) patients had inguinal hernias, 19 (33%) patients had
umbilical hernias and 12 (21%) patients had femoral hernias. Of the 57
patients, 51% had no previous symptoms; 23% had symptoms but were not
seen by a GP regarding them. Only 15% of patients had consulted a surgeon
before. Approximately 50% of patients with inguinal hernias had no
symptoms whereas 75% of femoral hernia patients were asymptomatic.
Overall mortality was 5.2% and morbidity was 33%.
